↓ Skip to main content

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults

Overview of attention for article published in Vaccine, August 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 16,639)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Readers on

mendeley
233 Mendeley